Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


CRISPR gene editing proves safe in a clinical trial

CRISPR-CAS9 gene editing complex.

The CRISPR–Cas9 enzyme complex (blue and grey) edits DNA (purple). Participants in one of the earliest clinical trials of a CRISPR-based therapy experienced no serious side effects. Credit: Ella Maru Studio/Science Photo Library

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Nature 578, 195 (2020)




Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links